Clinical results of IMAT in adenocarcinoma prostate cancer

被引:0
作者
Gribaudo, S. [1 ]
Monetti, U. [1 ]
Mussano, A. [1 ]
La Sala, S. [1 ]
Di Gregorio, S. [1 ]
Richetto, V. [1 ]
Sardo, A. [1 ]
Trevisiol, E. [1 ]
Madon, E. [1 ]
Urgesi, A. [1 ]
机构
[1] OIRM, S Anna Hosp, Turin, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1079
引用
收藏
页码:S440 / S440
页数:1
相关论文
共 50 条
[21]   Clinical implementation of intensity modulated arc therapy (IMAT) for rectal cancer. [J].
Duthoy, W ;
De Gersem, W ;
Boterberg, T ;
Smeets, P ;
Peeters, M ;
De Neve, W .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :290S-290S
[22]   IMAT-SIM: A new method for the clinical dosimetry of intensity-modulated arc therapy (IMAT) [J].
Iori, Mauro ;
Cagni, Elisabetta ;
Nahum, Alan E. ;
Borasi, Giovanni .
MEDICAL PHYSICS, 2007, 34 (07) :2759-2773
[23]   Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results [J].
Zietman, AL ;
Prince, EA ;
Nakfoor, BM ;
Shipley, WU .
UROLOGY, 1997, 49 (3A) :74-83
[24]   Prostate cancer pathologic parameters and clinical outcome: Results from the cooperative prostate cancer tissue resource (CPCTR) [J].
Melarned, J ;
Datta, MW ;
Becich, MJ ;
Bosland, M ;
Dhir, R ;
Kajdacsy-Balla, A ;
Orenstein, J ;
Silver, S ;
Berman, JJ .
LABORATORY INVESTIGATION, 2003, 83 (01) :162A-162A
[25]   Prostate cancer pathologic parameters and clinical outcome: Results from the cooperative prostate cancer tissue resource (CPCTR) [J].
Melamed, J ;
Datta, MW ;
Becich, MJ ;
Bosland, M ;
Dhir, R ;
Kajdacsy-Balla, A ;
Orenstein, J ;
Silver, S ;
Berman, JJ .
MODERN PATHOLOGY, 2003, 16 (01) :162A-162A
[26]   Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer [J].
Manini, Claudia ;
Gonzalez, Alba ;
Buchser, David ;
Garcia-Olaverri, Jorge ;
Urresola, Arantza ;
Ezquerro, Ana ;
Fernandez, Iratxe ;
Llarena, Roberto ;
Zabalza, Inaki ;
Pulido, Rafael ;
Carracedo, Arkaitz ;
Gomez-Iturriaga, Alfonso ;
Lopez, Jose I. .
JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04) :1-9
[27]   Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer [J].
Duthoy, W ;
De Gersem, W ;
Vergote, K ;
Boterberg, T ;
Derie, C ;
Smeets, P ;
De Wagter, C ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03) :794-806
[28]   Clinical implementation of IMAT prostate treatment using Elekta synergy and ERGO++ treatment planning system [J].
Shiraishi, K. ;
Nakagawa, K. ;
Haga, A. ;
Ohtomo, K. ;
Okano, Y. ;
Oritate, T. ;
Yoda, K. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01) :S650-S650
[29]   Clinical results of patients with prostate cancer treated with intensitiy modulated radiotherapy [J].
Boehmer, D ;
Herschel, R ;
Bohsung, J ;
Eichwurzel, I ;
Badakhshi, H ;
Budach, V .
RADIOTHERAPY AND ONCOLOGY, 2004, 73 :S400-S400
[30]   Results of a multinational clinical audit for prostate cancer radiotherapy: the IROCA project [J].
Lopes de Castro, C. ;
Fundowicz, M. ;
Rosello, A. ;
Jove, J. ;
Deantonio, L. ;
Aguiar, A. ;
Pisani, C. ;
Villa, S. ;
Boladeras, A. ;
Konstanty, E. ;
Kruszyna-Mochalska, M. ;
Milecki, P. ;
Jurado-Bruggeman, D. ;
Lencart, J. ;
Modolell, I. ;
Munoz-Montplet, C. ;
Aliste, L. ;
Torras, M. G. ;
Puigdemont, M. ;
Carvalho, L. ;
Krengli, M. ;
Guedea, F. ;
Malicki, J. .
RADIOTHERAPY AND ONCOLOGY, 2020, 152 :S618-S618